Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FU809
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,211
Award facts
- Contract value 100% obligated
- $33,211.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $33,211.09 with a firm fixed price, was awarded on December 16, 2025, to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The contract is funded by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for providing logistics and supply chain support to military and federal healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. No set-aside designation was used in this competitive procurement.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, medical supplies, and specialized healthcare commodities to support military healthcare programs and other federal medical systems worldwide. The award demonstrates AmerisourceBergen's continued role as a critical vendor in the federal pharmaceutical supply chain, delivering essential medications across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FU809?
SPE2DR26FU809 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FU809 worth?
The government has obligated $33,211 on SPE2DR26FU809.
Is contract SPE2DR26FU809 an order under another contract?
Yes. SPE2DR26FU809 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU809 competed?
The extent of competition for SPE2DR26FU809 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award